| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 02/13/2003 | WO2003011302A1 Androgen receptor modulators and methods of use thereof |
| 02/13/2003 | WO2003011297A1 N3-substituted 6-anilinopyrimidines and methods to treat gram-positive bacterial and mycoplasmal infections |
| 02/13/2003 | WO2003011288A1 Novel imidazolidine derivatives, their preparation and their use as vla-4 antagonists |
| 02/13/2003 | WO2003011287A1 Pyrazolon derivatives as inhibitors of gsk-3 |
| 02/13/2003 | WO2003011219A2 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 02/13/2003 | WO2002040462A3 Cysteine protease inhibitors |
| 02/13/2003 | US20030033089 Substituted quinazolines and analogs and the use thereof |
| 02/13/2003 | US20030032809 Mixing a carboxylic acid salt of paroxetine with hydrogen chloride and isolating the amorphous paroxetine |
| 02/13/2003 | US20030032654 Useful for the treatment or prevention of asthma and other allergic diseases. |
| 02/13/2003 | US20030032623 E.g., 1-(2-(1-adamantyl)ethyl)-1-pentyl-3-(3-(4-pyridyl)propyl)urea; useful as therapeutic agents for autoimmune diseases such as rheumatoid arthritis. |
| 02/13/2003 | CA2468925A1 Platelet adp receptor inhibitors |
| 02/13/2003 | CA2456187A1 Pyrazole-derived kinase inhibitors and uses thereof |
| 02/13/2003 | CA2455179A1 Androgen receptor modulators and methods of use thereof |
| 02/13/2003 | CA2455100A1 Mediators of hedgehog signaling pathways,compositions and uses related thereto |
| 02/13/2003 | CA2453577A1 Reductive cleavage of the exocyclic ester of uk-2a or its derivatives and products formed therefrom |
| 02/12/2003 | EP1283208A1 Novel benzofuran derivatives |
| 02/12/2003 | EP1283199A1 Melanin-concentrating hormone antagonist |
| 02/12/2003 | EP1283055A1 Soluble beta amyloid precursor protein secretion promoters |
| 02/12/2003 | EP1282618A2 9-oxa-epothilon derivatives, method for the production and use thereof in pharmaceutical preparations |
| 02/12/2003 | EP1282617A1 Hydantoin derivatives with affinity for somatostatin receptors |
| 02/12/2003 | EP1282616A1 Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatement of pain |
| 02/12/2003 | EP1282614A1 Hydroxamic acid derivatives |
| 02/12/2003 | EP1282609A2 Piperazinedione compounds |
| 02/12/2003 | EP1282605A2 Thioimidazolidine derivatives as light stabilisers for polymers |
| 02/12/2003 | EP1282600A1 Inhibitors of dipeptidyl peptidase iv |
| 02/12/2003 | EP1282418A2 Use of pyrazole derivatives for treating infertility |
| 02/12/2003 | EP0988292B1 Piperazine derivatives and their use as anti-inflammatory agents |
| 02/12/2003 | EP0926146B1 Chromene compounds |
| 02/12/2003 | CN1397148A Luminescent element material and luminescent element comprising the same |
| 02/12/2003 | CN1396920A 1,3-disubstituted pyrrolidines as alpha-2-adrenoceptor antagonists |
| 02/12/2003 | CN1396833A Integrin expression inhibitors |
| 02/12/2003 | CN1396807A 除草组合物 Herbicidal compositions |
| 02/12/2003 | CN1101397C Preparation of beta-methyl carbepenem intermediate |
| 02/12/2003 | CN1101392C Farnesyl protein transferase inhibiting (imidazol-5-yl)methyl-2-quindinone derivatives |
| 02/12/2003 | CN1101384C Process for preparing 1-biphenylmethylmidazole derivatives |
| 02/11/2003 | US6518431 Reacting 2,5-disubstituted pyridine with silalating agent |
| 02/11/2003 | US6518429 Anticancer agents, treating restenosis, atherosclerosis and hepatitis virus |
| 02/11/2003 | US6518305 Five-membered carbocyclic and heterocyclic inhibitors of neuraminidases |
| 02/11/2003 | US6518303 Selectively inhibit COX-2 in preference to COX-1 and are useful in the treatment of COX-2 mediated diseases, such as inflammation, pain, fever and asthma with fewer side effects |
| 02/11/2003 | US6518301 Better selectivity than estrogen for the estrogen receptor-beta over receptor-alpha; treatment of Alzheimer's disease, anxiety, depression, osteoporosis, cardiovascular disease, rheumatoid arthritis, or prostate cancer |
| 02/11/2003 | US6518292 Heterocyclic aromatic compounds usefuls as growth hormone secretagogues |
| 02/11/2003 | US6518289 1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders |
| 02/11/2003 | US6518286 Compounds |
| 02/11/2003 | US6518282 4-Arylpiperidine derivatives for the treatment of pruritus |
| 02/11/2003 | US6518279 Cyclopentanone dihydropyridine compounds useful as potassium channel openers |
| 02/11/2003 | US6518273 2-aryl indole derivative as antagonists of tachykinins |
| 02/11/2003 | US6518267 Protease inhibitors |
| 02/11/2003 | US6518264 For treatment/prevention of psychoses, other brain disorders, and cardiovascular disorders |
| 02/11/2003 | CA2250391C Butadiene derivatives and process for their preparation |
| 02/11/2003 | CA2047237C Chroman derivatives |
| 02/09/2003 | CA2397150A1 Complex and method for producing epoxides by using the complex |
| 02/06/2003 | WO2003010179A1 Process for the preparation of 2'-3'-dideoxy-2',3'-didehydro-nucleosides |
| 02/06/2003 | WO2003010141A2 Hepatitis c virus polymerase inhibitors with a heterobicyclic structure |
| 02/06/2003 | WO2003010140A2 Hepatitis c virus polymerase inhibitors with heterobicyclic structure |
| 02/06/2003 | WO2003009847A1 Substituted piperidines as modulators of the melanocortin receptor |
| 02/06/2003 | WO2003009841A1 Novel pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine |
| 02/06/2003 | WO2003009835A2 Novel use of 2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane and its physiologically acceptable salts |
| 02/06/2003 | WO2002079146A3 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same |
| 02/06/2003 | WO2002070516A3 Cyclopropaheterocycles as non-nucleoside reverse transcriptase inhibitors |
| 02/06/2003 | WO2002064586A3 Heterocyclic inhibitors of erk2 and uses thereof |
| 02/06/2003 | WO2002059112A3 Pyrazole compounds useful as protein kinase inhibitors |
| 02/06/2003 | WO2002048134A3 Di-substituted aminomethyl chroman derivative beta-3 adrenoreceptor agonists |
| 02/06/2003 | WO2002046172A3 Substituted 1, 3, 5-triazines and pyrimidines as abca-1 elevating compounds against coronary artery disease or atherosclerosis |
| 02/06/2003 | WO2002046141A3 Coumpounds of the formula r1-x-y-z-nr2r3 as abca-1 elevating agents against coronary artery disease or atherosclerosis |
| 02/06/2003 | WO2002041843A3 Antiinflammation agents |
| 02/06/2003 | WO2002032871A3 Compounds and methods for treating multidrug resistance |
| 02/06/2003 | WO2002010137A9 Indazole derivatives as jnk inhibitors |
| 02/06/2003 | US20030028027 Paroxetine maleate |
| 02/06/2003 | US20030028022 Preferably tertiary amines comprising tetrahydroquinoline and benzimidazole; use treating human immunodeficiency virus (HIV) and Feline Immunodeficiency Virus (FIV) |
| 02/06/2003 | US20030028019 Changes quickly into state of being colored in yellowish to reddish color tone upon irradiation with light containing ultraviolet rays such as of sunlight or light from mercury lamp, change being reversible; photochromic lenses |
| 02/06/2003 | US20030028018 Treating diseases characterized by activity of vascular endothelial growth factor receptor tyrosine kinases such as cancer |
| 02/06/2003 | US20030027857 Tocotrienol derivative, process for producing the same and gamma-CEHC delivering agent |
| 02/06/2003 | US20030027847 Carboxyformylacetamide derivatives for treatment of AIDS or ARC |
| 02/06/2003 | US20030027845 Ether derivatives useful as inhibitors of PDE4 isozymes |
| 02/06/2003 | US20030027836 Arylalkoxy-substituted tetrahydroisoquinoline-3-carboxylic acids or esters |
| 02/06/2003 | US20030027823 N,N'-disubstituted benzimidazolone derivatives with affinity at the serotonin and dopamine receptors |
| 02/06/2003 | US20030027814 Bis(5-aryl-2-pyridyl) compound having excellent immunoglobulin (IgE) antibody production inhibiting activity, useful for the prevention or treatment of allergic immune diseases |
| 02/06/2003 | US20030027810 Nicotine receptor ligands |
| 02/06/2003 | US20030027797 For therapy of metabolic disorders related to insulin resistance or hyperglycemia |
| 02/06/2003 | US20030027794 N-heterocyclic derivatives as NOS inhibitors |
| 02/06/2003 | US20030026521 Optical interleaver |
| 02/06/2003 | CA2452328A1 Substituted piperidines as modulators of the melanocortin receptor |
| 02/05/2003 | EP1281710A1 2H-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof |
| 02/05/2003 | EP1281709A1 Novel heterocyclic compounds with anti-inflammatory activity |
| 02/05/2003 | EP1280799A1 Ortho-substituted anthranilic acid amides and their use as medicaments |
| 02/05/2003 | EP1280798A1 Bicyclic heterocylces, medicaments containing said compounds, the use thereof and method for producing them |
| 02/05/2003 | EP1280796A1 Pyrimidinyl methyl indole derivatives with antibacterial activity |
| 02/05/2003 | EP1280793A2 Cyclic amidine compounds and their use as alpha4beta2 nicotinic acetylcholine receptor ligands |
| 02/05/2003 | EP1280789A1 Cdk inhibitors having 3-hydroxychromen-4-one structure |
| 02/05/2003 | EP1280781A1 5-ht 7 receptor antagonists |
| 02/05/2003 | EP1280777A1 Tetrahydroisoquinoline analogs useful as growth hormone secretagogues |
| 02/05/2003 | EP1280773A1 5-aryl-1.3.3.-trimethyl-2-methylene-indoline derivatives and salts thereof, methods for the production and use of said compounds for the temporary coloration of fibres |
| 02/05/2003 | EP1280765A2 Fluorous tagging compounds and their use |
| 02/05/2003 | EP1117653B1 Quinoline and quinazoline derivatives and their use as inhibitors of cytokine mediated diseases |
| 02/05/2003 | EP0938311B1 Use of efaroxan for producing medicine for treating huntington disease |
| 02/05/2003 | EP0848706B1 Substituted benzene-fused heterocyclics as neurokinin antagonists |
| 02/05/2003 | CN1395577A Ethanol solvate of (-)-cis-2-2(2-chlorophenyl)-5, 7-dihydroxy-8[4R-(3S-hydroxy-1-1methyl) piperidinyl]-4H-1-benzopyran-4-one |
| 02/05/2003 | CN1395576A Pseudopolymorph of (-)-cis-2-(2-chlorophenyl)-5, 7-dihydroxy-8[4R-(3S-hydroxy-1-methyl) piperidinyl]-4H-1-benzopyran-4-one |
| 02/05/2003 | CN1395575A Novel piperidine compounds and drugs containing the same |
| 02/05/2003 | CN1395568A 1,2-diaryl benzimidazole derivative for treating illnesses associated with microglia activation |